Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Claritin, Zyrtec And Visine Products Flood Eye Drop Market

This article was originally published in The Tan Sheet

Executive Summary

Schering-Plough and Johnson & Johnson are taking different strategies to promote near-identical allergy-relief eye drops launched almost simultaneously
Advertisement

Related Content

"Real People" Offer Effective, Less Costly Alternatives To Celebrity Endorsers
"Real People" Offer Effective, Less Costly Alternatives To Celebrity Endorsers
"Real People" Offer Effective, Less Costly Alternatives To Celebrity Endorsers
Zyrtec and Claritin Eye Drops Use Different Tactics In Head To Head Fight
Zyrtec and Claritin Eye Drops Use Different Tactics In Head To Head Fight
Zyrtec and Claritin Eye Drops Use Different Tactics In Head To Head Fight
Pharma Firms Stir OTC Market, FDA Hones Enforcement: Top Stories Of 2009
Claritin 12-Hour Takes Aim At Shorter-Duration Allergy Drugs
J&J Zyrtec Pediatric Spoon Marks Increased Role For Dosing Innovations
J&J Zyrtec Pediatric Spoon Marks Increased Role For Dosing Innovations

Topics

Advertisement
UsernamePublicRestriction

Register

PS103270

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel